IDEAS home Printed from https://ideas.repec.org/a/bhx/ojijhs/v3y2020i1p37-42id238.html
   My bibliography  Save this article

First Line Anti-Retro Viral Drugs Disrupts The Estrus Cycle Of Wistar Rats

Author

Listed:
  • Dr Aigbe Gregory Ohihoin

Abstract

Background: Patients with HIV AIDS are beginning to live longer and healthier lives due to the use of ARV therapy. The effect of long term usage of these agents on the reproductive potential of human females has not been well studied. The study of the estrus cycle in rats will give information on the possible effect of ARV's on the reproductive potential of humans.Aims: To elucidate the effects of the first-line ARV's, Efavirenz, Tenofovir and Lamivudine administered in a combined fashion, on the oestrous cycle of adult female Wistar rats.Material and Methods: Twenty-five female Wistar rats with a mean weight of 158.76g were used. A total of five groups of rats were involved in the study. Five rats were apportioned to each study group. All three ARV's were administered orally in a combined fashion to a particular group of Female Wistar rats and also administered individually to other groups while the control group received water. The estrous cycles of various groups of rats were monitored via microscopic analysis of their vaginal smearsResults: The control group had a consistently regular cycle, while the cycles of the rats in the combination therapy group and the rats that received efavirenz alone, became elongated relative to the control group. There was a 48-hour enlongated proestrous phase some of the rats.Conclusions: First-line ARV's - Tenofovir, Efavirenz, and Lamivudine- disrupt the estrous cycle of adult rats. Further investigation of the long term usage of these drugs on the menstrual cycle of human females is therefore necessary

Suggested Citation

  • Dr Aigbe Gregory Ohihoin, 2020. "First Line Anti-Retro Viral Drugs Disrupts The Estrus Cycle Of Wistar Rats," International Journal of Health Sciences, CARI Journals Limited, vol. 3(1), pages 37-42.
  • Handle: RePEc:bhx:ojijhs:v:3:y:2020:i:1:p:37-42:id:238
    as

    Download full text from publisher

    File URL: https://carijournals.org/journals/index.php/IJHS/article/view/238/360
    Download Restriction: Access to full texts is restricted to International Journal of Health Sciences
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Keywords

    antiretroviral; disrupt; cycle;
    All these keywords.

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bhx:ojijhs:v:3:y:2020:i:1:p:37-42:id:238. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chief Editor (email available below). General contact details of provider: https://www.carijournals.org/journals/index.php/IJHS/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.